Mrs Pamela Gaye Jinks, OTR/ L CHT | |
2270 N Perkins Rd, Stillwater, OK 74075-3078 | |
(405) 780-9919 | |
(405) 780-9920 |
Full Name | Mrs Pamela Gaye Jinks |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 2270 N Perkins Rd, Stillwater, Oklahoma |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1891764452 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | OT439 (Oklahoma) | Primary |
225XH1200X | Occupational Therapist - Hand | OT439 (Oklahoma) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Mrs Pamela Gaye Jinks, OTR/ L CHT 2270 N Perkins Rd, Stillwater, OK 74075-3078 Ph: (405) 780-9919 | Mrs Pamela Gaye Jinks, OTR/ L CHT 2270 N Perkins Rd, Stillwater, OK 74075-3078 Ph: (405) 780-9919 |
News Archive
Neurocrine Biosciences, Inc. today announced efficacy and safety results from a Phase II trial of urocortin 2 in 53 patients with acute decompensated heart failure. The UNICORN study was conducted over approximately a two year period by the Cardioendocrine Research Group from the University of Otago in Christchurch, New Zealand and included patients admitted to Christchurch Hospital with acute decompensated heart failure.
Extending an unmatched record of innovation in the field of endovascular aortic repair, Medtronic, Inc., today announced the U.S. market launch of the Talent Thoracic Stent Graft on the Xcelerant Delivery System, which makes minimally-invasive treatment of thoracic aortic aneurysms easier to perform.
CANCER RESEARCH UK will be supported by AstraZeneca and Pfizer in a multimillion pound initiative to examine how genetic tests to improve cancer diagnosis can be best rolled out across the NHS.
Par Pharmaceutical Companies, Inc. today announced that its generic division, Par Pharmaceutical, has entered into an exclusive licensing agreement with Glenmark Generics Limited and Glenmark Generics Inc., USA to market ezetimibe 10 mg tablets, the generic version of Merck & Co. Inc.'s Zetia, in the U.S. Zetia is a cholesterol modifying agent with annual U.S. sales of approximately $1.4 billion, according to IMS Health data.
Scripps Research Institute scientists have converted adult skin cells directly into beating heart cells efficiently without having to first go through the laborious process of generating embryonic-like stem cells. The powerful general technology platform could lead to new treatments for a range of diseases and injuries involving cell loss or damage, such as heart disease, Parkinson's, and Alzheimer's disease.
› Verified 7 days ago
William Mclean, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1321 W 7th Ave, Stillwater, OK 74074 Phone: 405-372-7200 | |
Amy Ramer, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 811 E Virginia Ave, Stillwater, OK 74075 Phone: 405-377-8255 | |
Morgan Mason, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 811 E Virginia Ave, Stillwater, OK 74075 Phone: 405-377-8255 | |
Mara Hunziker, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1323 W 6th Ave, Stillwater, OK 74074 Phone: 405-334-7652 | |
Mrs. Tamara Patocka Wales, O.T. Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 120 N Perkins Rd Ste F, Stillwater, OK 74075 Phone: 405-564-2701 | |
Mrs. Nancy Beth Mclean, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2324 W 10th Ave, Stillwater, OK 74074 Phone: 405-334-7443 |